Sanofi Pasteur announces publication of positive data for Fluzone® high-dose vaccine in The New England Journal of Medicine
14 August 2014 | By Sanofi
Sanofi Pasteur announced that The New England Journal of Medicine published positive results from a large-scale, multi-center efficacy trial, which found that Fluzone® High-Dose (Influenza Vaccine) was more efficacious in preventing influenza...